Scientists at Imperial College London develop blood test for diagnosing glioblastoma, potentially revolutionizing early detection and treatment.

A blood test may soon diagnose patients with the deadliest form of brain cancer, sparing them from undergoing invasive surgery. Scientists at Imperial College London have developed a new technique to diagnose glial tumors, including glioblastoma, the most common type of high-grade brain tumor in adults. The test, published in the International Journal of Cancer, could potentially revolutionize the treatment of this life-threatening condition, enabling early detection and less risky procedures.

January 26, 2024
89 Articles